about
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.A comparative analysis on the efficacy and safety of intaxel® and taxol® in advanced metastatic breast cancer.Combined dabrafenib and trametinib treatment in a case of chemotherapy-refractory extrahepatic BRAF V600E mutant cholangiocarcinoma: dramatic clinical and radiological response with a confusing synchronic new liver lesionSerum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinomaOccurrence of bladder metastasis 10 years after surgical removal of a primary gastric cancer: a case report and review of the literature.Clinical Outcomes of 130 Patients with Primary and Secondary Lung Tumors treated with Cyberknife Robotic Stereotactic Body Radiotherapy.Recent Advances in the Neoadjuvant Treatment of Breast Cancer.[The standardized mortality numbers of patients with gastrointestinal tumors and cardiovascular diseases in four wine regions and in one not-wine region of Hungary between 2000-2010].[Triple-negative breast carcinoma--rewiev of current literature].[Pharmaceutical therapy of breast cancer].Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.[The role of adjuvant clodronate therapy for prevention of bone metastasis in breast cancer].Case 3. Resection of originally inoperable liver metastases of gastrointestinal stromal tumor after imatinib mesylate therapy.Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study.Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer.An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis.[Role of PET/CT in diagnosis and treatment of breast cancer -- review of present knowledge and perspectives for future research].[Modern diagnostics in breast cancer: nuclear medicine techniques].[Modern pharmacological therapy of breast cancer].Levél az emlőrák felismerésétől az emlőrákos betegek rehabilitációjáig tartó folyamat javításának érdekében.Three-year results of the first educational and early detection program for testicular cancer in Hungary[Early diagnosis of testicular cancer][The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer]Significance of histomorphology of early triple-negative breast cancer[Challenges in oncologic plastic surgery of the breast][Implementation of cone beam CT-guided volumetric modulated arc therapy and establishment of related institutional quality assurance protocols]Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: a phase 2 study[Quality of life analysis of postmenopausal, early breast cancer patients treated with anastrozole (RADAR-II)][Systemic therapy of breast cancer: practice guideline]
P50
Q27851705-EBE95D96-378C-4064-89C3-9DEC6C403C8BQ33409451-864254F4-C8A0-4A7B-80A2-3946182A2681Q33593231-10CA2FCF-16D5-4039-AB8B-14EF3FE4D196Q35904795-37199AFF-E3E4-44F2-9027-353F9E744E5DQ37153623-D29F02E7-9968-467D-8C3B-9F02B8500E29Q38663392-C4A8AD80-8537-4813-BA1B-AF8C4C661BCBQ38687392-C08BA71B-581E-43EA-AF11-CFFBFE65FBC9Q40154717-C902C296-B88B-4E3B-837B-DA9E5323E7F3Q42777188-AB1EA1BC-6DF3-4E3A-9269-67BDC76CDC60Q42876572-3B2CE2DD-5CDD-4BD4-B0DA-57E4B6D685CAQ43529510-9AC55E28-6D4F-479C-965B-5FAD36371431Q44300469-842B3F3C-0432-4B05-83BF-D3348E8E39CCQ44583978-ED73BE42-9BA3-49A5-9432-9B83040CCC67Q47971076-D3F3C7E4-060C-4729-807D-384071084472Q48214785-9AF2A6B7-6632-4714-9135-4C0EAEAD1D13Q52638911-3BAC7966-4537-4CBE-B483-4EA7E1D60F03Q52673670-FC061866-FA65-4CF6-9FD3-0CDBF12FC404Q53171880-FCA148ED-8A1C-4A55-9BE4-4D06D1317D37Q53183150-F624F4FA-F308-46B9-98EE-CD4F7E7BB00BQ54538595-59BF13EB-0E94-4995-9CDD-2E4938F22016Q54782600-7B35DB36-77F6-4E5B-8CED-0475E9977B4CQ73843930-A47F7DF6-7281-43EF-845A-F4B4F28C7EC2Q74246869-70D99731-3C06-47EE-8C12-02CF7CA652EAQ83159647-F67C956B-F0E5-433F-B162-88AC1DD5C194Q83640557-CB629469-76AF-47DC-B31A-CF312E23F6E3Q84206412-0762F7C0-1D49-4165-AB54-0E6A79B186C5Q85278067-32942A85-C470-42A0-8CF2-2AD478CB5119Q85640601-72D640A2-48F0-48C7-B200-7351AA674141Q85649163-2183D1AF-D782-4BD5-A93A-91AE730D59F3Q95521112-A66C26A7-CDBE-4AC0-9E2F-55CB79A5FC3D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Zsolt Horváth
@ast
Zsolt Horváth
@en
Zsolt Horváth
@es
Zsolt Horváth
@nl
Zsolt Horváth
@sl
type
label
Zsolt Horváth
@ast
Zsolt Horváth
@en
Zsolt Horváth
@es
Zsolt Horváth
@nl
Zsolt Horváth
@sl
prefLabel
Zsolt Horváth
@ast
Zsolt Horváth
@en
Zsolt Horváth
@es
Zsolt Horváth
@nl
Zsolt Horváth
@sl
P106
P31
P496
0000-0002-5376-7737